93250 ⎘
Derivatives of guanidine, i.e. compounds containing the group , the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
CELLULAR ENERGY COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF
#2Cycloheptylamine derivatives as anti-diabetic agents
#3Cycloheptylamine derivatives as anti-diabetic agents
#4Class A GPCR-binding compound modifier
#5GUANIDINE CATALYST FOR CURABLE COMPOSITIONS
#6ANTI-INFLAMMATORY DRUG AND USES THEREOF
#7Inhibitors of creatine transport and uses thereof
#8Ion pair catalysis of tungstate and molybdate
#9Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
#10Bridged nucleic acid GuNA, method for producing same, and intermediate compound
#11SHIP1 modulators and methods related thereto
#12ANTI-INFLAMMATORY DRUG AND USES THEREOF
#13Sphingosine kinase inhibitors
#14Amidine group—or guanidine group—containing silane
#15Guanidine compounds and use thereof
#16Inhibitors of creatine transport and uses thereof
#17Rapid-curing, migration-free composition based on organic polymers containing silane groups
#18Borate-based base generator, and base-reactive composition comprising such base generator
#19Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
#20SHIP1 modulators and methods related thereto
#21Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
#22SHIP1 MODULATORS AND METHODS RELATED THERETO
#23Long chain base sphingosine kinase inhibitors
#24(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof
#25CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof
#26Compounds for the treatment of influenza
#27Neuraminidase Inhibitors
#28Prodrugs of neuraminidase inhibitors
#29Blends comprising epoxy resins and mixtures of amines with guanidine derivatives
#30Chemically Programmed Vaccination
#31(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentyl-l-carboxylic acid hydrates pharmaceutical uses thereof
#32Fluorosubstituted-(3R,4R,5S)-5-guanidino 4-acetamido-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid compound, ester and use thereof
#33Synthesis of bicyclic compounds and method for their use as therapeutic agents
#34Neuraminidase Inhibitors
#35Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
#36Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
#37Prodrugs of Neuraminidase Inhibitors
#38COMPOUNDS AND METHODS FOR TREATMENT OF INFLUENZA
#39Chemically programmed vaccination
#40Blends comprising epoxy resins and mixtures of amines with guanidine derivatives
#41Process for preparing moldings using mixtures of amines with guanidine derivatives
#42Anti-Heparin Compounds
#43Prodrugs of Neuraminidase Inhibitors
#44Compounds having a guanidine structure and use of same as organopolysiloxane polycondensation catalysts
#45(1S,2S,3S,4R)-3-[(1S)-1-ACETYLAMINO-2-ETHYL-BUTYL]-4-UANIDINO-2-HYDROXYL-CYCLOPENTYL-1-CARBOXYLIC ACID HYDRATES PHARMACEUTICAL USES THEREOF
#46Methods of use of antiviral compounds
#47METHODS OF USE OF ANTIVIRAL COMPOUNDS
#48Aminoazoline and Urea Derivatives for Combating Animal Pests
#49Guanidine derivatives as inhibitors of DDAH
#50CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#51Cycloalkyl inhibitors of potassium channel function